Initial jobless claims jumped 9.8% to a seasonally adjusted 360,000 for the week ending May 11, according to a Labor Department report released today.
Last week's unrevised initial jobless claims marked a record recovery low, but this newest report puts the labor market back in bear territory. Analysts had expected a slight rise in claims, but their 330,000 prediction�underestimated the increase.
Source: Author, data from Labor Department.�
The four-week moving average also increased, up 0.4%�after three straight weeks of declines. Despite the increases in claims, both the most recent week's number and the moving average clock in solidly below 400,000, a cutoff point that economists consider a sign of an improving labor market.
Top 10 Penny Stocks To Own For 2015: Western Asset Mortgage Capital Corp (WMC)
Western Asset Mortgage Capital Corporation is focused on investing in, financing and managing primarily residential mortgage-backed securities (RMBS), which are not issued or guaranteed by a United States Government agency or federally chartered corporation, or non-Agency RMBS. The Company also focuses on investing in commercial mortgage-backed securities (CMBS), and other asset-backed securities (ABS), as well as RMBS for which a United States Government agency or federally chartered corporation guarantees payments of principal and interest on the securities, or Agency RMBS.
The Company is managed and advised by Western Asset Management Company. As of June 12, 2009, the Company had not made any investments.
Advisors' Opinion:- [By Eric Volkman]
Western Asset Mortgage Capital (NYSE: WMC ) has shaved its dividend. The company has declared a payout for its Q2 of $0.90 per share, to be paid on July 29 to shareholders of record as of July 1. That amount is $0.05, or 5%, lower than the mortgage REIT's previous distribution of $0.95, which was handed out at the end of April.
- [By Lawrence Meyers]
Today, we’re looking at three dividend stocks with sky-high dividend yields to see whether they’re safe.
Western Asset Mortgage Capital Corporation (WMC)Dividend Yield: 19.8%
- [By Amanda Alix]
Second-quarter upset
As if that news wasn't bad enough, book value took a nasty hit, too. The drop from $12.87 at the end of March to $10.20 at the end of June was huge, even considering the $0.34 dividend paid on June 10. Earlier in the day, Deutsche Bank had downgraded a handful of mREITs, including Western Asset Mortgage (NYSE: WMC ) , based on book value declines of up to 16% during the second quarter. CYS, even factoring in its payout, suffered a drop of closer to 19%. - [By Rick Munarriz]
Western Asset Mortgage Capital (NYSE: WMC ) is also beefing up its yield. The REIT that snaps up residential mortgage-backed securities and shells out most of the housing payments to its stakeholders is boosting its quarterly rate by 5% to $0.95 a share.
5 Best Stocks To Own Right Now: Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals, Inc. (Supernus), incorporated on March 30, 2005, is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder (ADHD). Supernus�� two epilepsy product candidates are SPN-538 and Epliga. Epliga is in Phase III clinical trials. Supernus ADHD product candidates include SPN-810 (molindone hydrochloride), a treatment for impulsive aggression in patients with ADHD, and SPN-812, a non-stimulant treatment for ADHD. Both of these programs are in Phase II. In addition to these four products candidates, Supernus has several additional product candidates in various stages of development, including SPN-809. Its wholly owned subsidiary includes TCD Royalty Sub LLC.
Supernus�� Late-Stage Neurology Portfolio
SPN-538 is an oral once-daily extended release topiramate product for the treatment of epilepsy. Topiramate is marketed by Johnson & Johnson under the brand name Topamax and is available in a generic form. As of December 31, 2009, Topiramate was available only in immediate release form and is indicated for monotherapy and adjunctive therapy of epilepsy and for the treatment of migraine. It works by enhancing the inhibitory effect of the Gamma-Aminobutyric Acid (GABA) neurotransmitter that regulates neuronal excitability throughout the nervous system, blocking the excitatory effect of the glutamate neurotransmitter, blocking the sodium channel and inhibiting the carbonic anhydrase enzyme.
Epliga is an oral once-daily extended release formulation of oxcarbazepine. As of December 31, 2009, Epliga was in Phase III trials. Oxcarbazepine is marketed by Novartis under the brand name Trileptal and is available in a generic form. Trileptal is indicated for monotherap! y and adjunctive therapy of epilepsy. Oxcarbazepine is an active voltage-dependent sodium channel blocker.
Supernus�� Psychiatry Portfolio
SPN-810 (molindone hydrochloride) is a treatment for impulsive aggression in patients with ADHD. As of December 31, 2009, it was in Phase II. SPN-810 is based on molindone hydrochloride. As of December 31, 2009, the Company had completed four clinical trials for SPN-810, including a Phase IIa trial, in which it tested the safety and tolerability of immediate release molindone hydrochloride in children with ADHD who suffer from serious persistent conduct problems. This open-label, dose-ranging trial randomized 78 children, 6-12 years of age, into one of four treatment groups, which were given four different doses of immediate release molindone hydrochloride, between 10 milligram and 40 milligram per day, depending on weight, three times a day over a six-week treatment period, after 2-5 weeks of titration. SPN-810 was well tolerated in the trial with no clinically meaningful changes in standard hematology, clinical chemistry values, vital signs or electrocardiogram results. SPN-810 also showed improvements on the primary and secondary outcome measures, such as conduct problem and ADHD scales, across all four treatment groups. SPN-812 is a non-stimulant treatment for ADHD. As of December 31, 2009, SPN-812 was in Phase II. SPN-812 is a selective norepinephrine reuptake inhibitor.
Supernus�� Technology Platforms
The Company has a long track record of developing products by applying technologies to known drugs to improve existing therapies and to enable the treatment of new indications. Supernus�� main technology platforms include: Microtrol (multiparticulate delivery platform), Solutrol (matrix delivery platform) and EnSoTrol (osmotic delivery system). The Company�� technologies have been used in the approved and marketed products, including Carbatrol (carbamazepine), Equetro (carbamazepine), Adderall XR (mixe! d ampheta! mine salts), Sanctura XR (trospium chloride), Oracea (doxycycline) and Intuniv (guanfacine).
Advisors' Opinion:- [By Wallace Witkowski]
Shares of Supernus Pharmaceuticals (SUPN) �jumped 20% after hours Monday after a drug on which the firm collaborated received Food and Drug Administration approval.
- [By Monica Gerson]
Supernus Pharmaceuticals (NASDAQ: SUPN) confirmed the FDA approval of its partner's heart blood-pressure treatment. Supernus shares jumped 18.24% to $8.75 in after-hours trading.
5 Best Stocks To Own Right Now: George Risk Industries Inc (RSKIA)
George Risk Industries, Inc. (GRI), incorporated on February 21, 1961, is engaged in the design, manufacture and sale of computer keyboards, push button switches, burglar alarm components and systems, pool alarms, thermostats, EZ Duct wire covers and water sensors. GRI is a diversified manufacturer of electronic components, consisting of the security industries variety of door and window contact switches, environmental products, proximity switches and custom keyboards. The Company operates in two segments: security alarm products and security alarm products GRI�� security burglar alarm products comprise approximately 84% of net revenues and are sold through distributors and alarm dealers/installers. These products are used for residential, commercial, industrial and government installations. Its products include security products/ magnetic reed switches, data entry peripherals, pushbutton switches, custom engraved keycaps and proximity sensors.
The security segment has approximately 3,000 customers. One of the distributors, ADI accounts for approximately 40% of the Company's sales of these products. The keyboard segment has approximately 800 customers. Keyboard products are sold to original equipment manufacturers to their specifications and to distributors of off-the-shelf keyboards of proprietary design. GRI owns and operates its main manufacturing plant and offices in Kimball, Nebraska with a satellite plant 40 miles away in Gering, Nebraska.
Advisors' Opinion:- [By Geoff Gannon]
So, I think of simple industries as food, entertainment, etc. And anything where logistics provide a competitive advantage. I mentioned a company I own shares of ��George Risk Industries (RSKIA) ��before. Its advantage is the ability to deliver a cheap product on time. They can't produce the product for less than the competition. If the purchase price was huge relative to what the end customer was purchasing as part of the same activity (the end customer is construction in this case) price competition would be important. Instead, delivery is important.
- [By Geoff Gannon] >Ark Restaurants (ARKR). When I bought them - and even now - I think their return on buyback would be high and I'd be in favor of it. However, the stocks are illiquid and their free cash flow relative to the dollar value of freely traded shares is not high. As a result, I'm always in favor of RSKIA and ARKR buying back stock. But, I understand it's very hard for them to do in practice unless there is a meaningful holder who signals he wants out of the stock.
My approach to buybacks is pretty simple. One, I prefer them. Two, I look at the share count history over the last 10 to 20 years as my guide to what the company might do in the future - I want a pattern of predictable behavior. Generally, that means a continuously shrinking share count that shrinks in bull markets and bear markets, panics and recessions and booms and busts and so on. Three, if I'm a buyer of the stock - then the company should be a buyer of its own stock. No questions asked on that one. If the stock is good enough for me to buy it's clearly good enough for the company to buy. Finally, I look for the return on buyback. I tend to focus on the earning power the company is buying relative to the net cash it is spending. If a company has cash on its balance sheet, the amount of net cash consumed by a buyback will be less than it appears because I will end up with a greater percentage ownership of the resulting balance sheet as well as the income statement.
I want the return on buyback to always be at least 10%. As a rule, the average company will only get returns on its buybacks of 10% or higher if it pays less than 15 times normal earnings. In special cases - fast growing companies, companies where free cash flow vastly exceeds reported income, etc. - it is possible that buybacks above 15 times earnings will return more than 10%. It almost never makes sense for a company to buy back stock at over 25 times earnings. So, for most companies, under 15 times earnings is the green zone for bu
- [By Geoff Gannon] n. When it traded around $4.50 (it�� now more like $7.50 a share) it was a net-net with a good business and a moat. There were risks ��customer concentration for one ��and it was no blue chip. There was no diversification of product lines, customers, geography, industry, etc. It was closely tied to U.S. construction activity.
All this means it was no blue chip. Not that it didn�� have a moat. I felt it did. And certainly not that it wasn�� a high quality business. It demonstrably was (unleveraged returns on tangible equity were around 30%). And it was a net-net. In fact, it was a net cash stock at one time.
So they do happen. But they are rare. The usual distinction with net-nets is not between companies like that ��companies which may have a moat, do earn good returns on capital, etc. ��but between companies that are legitimate and illegitimate businesses.
A legitimate business is ��in my mind ��a historically profitable one. It is likely to have positive retained earnings (there are exceptions to this rule ��but it�� a good first check). It should have more years of profits (6 or more) than losses in the last 10 years. And it should be self-financing.
Compare this to an illegitimate business. The least legitimate businesses are those that ��while publicly traded ��have never turned a profit and can�� self finance. They may be net-nets ��but they are net-nets because they have issued stock in the past and then seen their share prices drop. Retained earnings are often negative.
There are other factors to consider. Is the business old or young? Is depreciation ��and other accounting ��especially conservative or aggressive? Are taxes especially conservative or aggressive? And is share issuance dilutive or not.
I think a legitimate business tends towards LIFO accounting, quicker depreciation, higher taxes paid as a percentage of reported income, and lower share issuance. There are exceptions. Many
5 Best Stocks To Own Right Now: Clearwire Corporation(CLWR)
Clearwire Corporation, through its subsidiaries, provides fourth generation wireless broadband services in the United States. The company builds and operates mobile broadband networks that offer high-speed mobile Internet and residential Internet access services. It serves retail customers through its CLEAR brand. The company markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores; and through company-operated retail outlets. As of December 31, 2011, it had approximately 1.3 million retail and 9.1 million wholesale subscribers. The company is headquartered in Bellevue, Washington. Clearwire Corporation is a subsidiary of Sprint HoldCo LLC.
Advisors' Opinion:- [By Dan Radovsky]
DISH has been trying to get into the wireless communications business and has been accumulating spectrum licenses from bankrupt satellite companies. Late last year, it made a counteroffer to Sprint's bid to buy Clearwire (NASDAQ: CLWR ) .
No comments:
Post a Comment